Clearview Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-21
Closed -$434 453
2023
Q2
$434 Hold
21
﹤0.01% 640
2023
Q1
$510 Sell
21
-4
-16% -$107 ﹤0.01% 614
2022
Q4
$714 Sell
25
-2
-7% -$51 ﹤0.01% 549
2022
Q3
$1K Hold
27
﹤0.01% 543
2022
Q2
$1K Hold
27
﹤0.01% 551
2022
Q1
$1K Sell
27
-26
-49% -$889 ﹤0.01% 569
2021
Q4
$2K Sell
53
-61
-54% -$1.99K ﹤0.01% 593
2021
Q3
$4K Buy
+114
New +$3.65K ﹤0.01% 526

Other funds holding OGN

Clearview Wealth Advisors's OGN Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 21 shares — an estimated $434 sold.

Clearview Wealth Advisors first reported a position in OGN in Q3 2021 and held it in 8 quarters. The position peaked at $4K in Q3 2021. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 21 Organon & Co shares in Q3 2023, an estimated $434.
  • Clearview Wealth Advisors first reported a position in Organon & Co in Q3 2021 and held it in 8 quarters.
  • Clearview Wealth Advisors's Organon & Co position peaked at $4K in Q3 2021.
  • 730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.